4//SEC Filing
KAWAS LEEN 4
Accession 0001209191-21-012816
CIK 0001620463other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 5:33 PM ET
Size
5.5 KB
Accession
0001209191-21-012816
Insider Transaction Report
Form 4
KAWAS LEEN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-02-18+231,000→ 231,000 totalExercise: $21.15Exp: 2031-02-17→ Common Stock (231,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option will vest on January 8, 2022, and one-fourth of the shares subject to the option will vest on each year thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822491
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 5:33 PM ET
- Size
- 5.5 KB